Edition: BP 2025 (Ph. Eur. 11.6 update)<\/p>\n
General Notices<\/p>\n
Action and use<\/strong><\/p>\n Adrenoceptor agonist.<\/p>\n Ephedrine Hydrochloride Tablets contain Ephedrine Hydrochloride.<\/p>\n The tablets comply with the requirements stated under Tablets and with the following requirements.<\/p>\n Content of ephedrine hydrochloride, C10H15NO,HCl A.\u2003Shake a quantity of the tablets containing 0.1 g of Ephedrine Hydrochloride with 20 mL of 0.1M hydrochloric acid, filter, wash the filtrate with two 20 mL quantities of chloroform and discard the chloroform. Make the aqueous layer alkaline with 5M ammonia and extract with two 30 mL quantities of a mixture of 3 volumes of chloroform and 1 volume of ethanol (96%).<\/p>\n Dry the combined extracts over anhydrous sodium sulfate, filter and evaporate to a low volume at a pressure of 2 kPa. Prepare a disc using 0.3 g of potassium bromide, apply the chloroform solution to the surface of the disc and heat at 50\u00b0 for 2 minutes. The infrared absorption spectrum, Appendix II A, is concordant with the reference spectrum of ephedrine (RS 121).<\/p>\n B.\u2003In the test for Related substances, the principal spot in the chromatogram obtained with solution (2) corresponds to that in the chromatogram obtained with solution (3).<\/p>\n C.\u2003Triturate a quantity of the powdered tablets containing 0.4 g of Ephedrine Hydrochloride with two 10 mL quantities of chloroform and discard the chloroform. Macerate the residue with 30 mL of warm ethanol (96%) for 20 minutes, filter, evaporate the filtrate to dryness on a water bath and dry the residue at 80\u00b0. Dissolve 10 mg of the residue in 1 mL of water and add 0.1 mL of weak copper sulfate solution followed by 1 mL of 5M sodium hydroxide; a violet colour is produced. Add 1 mL of ether and shake; the ether layer is purple and the aqueous layer is blue.<\/p>\n Related substances<\/strong><\/p>\n Carry out the method for thin-layer chromatography, Appendix III A, using the following solutions.<\/p>\n (1)\u2003Extract a quantity of the powdered tablets containing 0.10 g of Ephedrine Hydrochloride with 5 mL of methanol, filter and use the filtrate.<\/p>\n (2)\u2003Dilute 1 volume of solution (1) to 10 volumes with methanol.<\/p>\n (3)\u20030.20% w\/v of ephedrine hydrochloride BPCRS in methanol.<\/p>\n (4)\u2003Dilute 1 volume of solution (1) to 200 volumes with methanol.<\/p>\n (a)\u2003Use as the coating silica gel G.<\/p>\n (b)\u2003Use the mobile phase as described below.<\/p>\n 5 volumes of chloroform, 15 volumes of 13.5M ammonia and 80 volumes of propan-2-ol.<\/p>\n Any secondary spot in the chromatogram obtained with solution (1) is not more intense than the spot in the chromatogram obtained with solution (4). Disregard any spot of lighter colour than the background.<\/p>\n Weigh and powder 20 tablets. Carry out the method for liquid chromatography, Appendix III D, using the following solutions.<\/p>\n (1)\u2003Shake a quantity of the powdered tablets containing 50 mg of Ephedrine Hydrochloride with 30 mL of methanol for 10 minutes, add sufficient water to produce 50 mL, filter through glass-fibre paper (Whatman GF\/C is suitable) and use the filtrate.<\/p>\n (2)\u20030.1% w\/v of ephedrine hydrochloride BPCRS in methanol (60%).<\/p>\n (a)\u2003Use a stainless steel column (20 cm \u00d7 4.6 mm) packed with end-capped octadecylsilyl silica gel for chromatography (10 \u00b5m) (Nucleosil C18 is suitable) 0.005M dioctyl sodium sulfosuccinate in a mixture of 1 volume of glacial acetic acid, 35 volumes of water and 65 volumes of methanol.<\/p>\n Calculate the content of C10H15NO,HCl using the declared content of C10H15NO,HCl in ephedrine hydrochloride BPCRS.<\/p>\n","protected":false},"excerpt":{"rendered":" Edition: BP 2025 (Ph. Eur. 11.6 update) General Notices Action and use Adrenoceptor agonist. DEFINITION Ephedrine Hydrochloride Tablets contain Ephedrine Hydrochloride. The tablets comply with the requirements stated under Tablets and with the following requirements. Content of ephedrine hydrochloride, C10H15NO,HCl92.5 to 107.5% of the stated amount. IDENTIFICATION A.\u2003Shake a quantity of the tablets containing 0.1…<\/p>\n","protected":false},"author":5,"featured_media":12173,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[175],"tags":[],"class_list":["post-12171","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-formulated-preparations-specific-monographs"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/12171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=12171"}],"version-history":[{"count":2,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/12171\/revisions"}],"predecessor-version":[{"id":12182,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/12171\/revisions\/12182"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/12173"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=12171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=12171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=12171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}DEFINITION<\/h2>\n
92.5 to 107.5% of the stated amount.<\/p>\nIDENTIFICATION<\/h2>\n
CHROMATOGRAPHIC CONDITIONS<\/h3>\n
MOBILE PHASE<\/h3>\n
LIMITS<\/h3>\n
ASSAY<\/h2>\n
CHROMATOGRAPHIC CONDITIONS<\/h3>\n
(b)\u2003Use isocratic elution and the mobile phase described below.
(c)\u2003Use a flow rate of 2 mL per minute.
(d)\u2003Use an ambient column temperature.
(e)\u2003Use a detection wavelength of 263 nm.
(f)\u2003Inject 20 \u00b5L of each solution.<\/p>\nMOBILE PHASE<\/h3>\n
DETERMINATION OF CONTENT<\/h3>\n